Recombinant Human IgG

Contact us
Leinco Technologies
Product Code: LEI-I-539
Product Group: Recombinant Proteins
CodeSizePrice
LEI-I-539-100ug100 ug£557.00
Quantity:
Prices exclude any Taxes / VAT

Overview

Host Type: Human
Regulatory Status: RUO
Shipping:
Ambient
Storage:
This lyophilized protein is stable for six to twelve months when stored desiccated at -20°C to -70°C. After aseptic reconstitution this protein may be stored at 2°C to 8°C for one month or at -20°C to -70°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles. See Product Insert for exact lot specific storage instructions.

Further Information

Format:
This recombinant protein was 0.2 um filtered and lyophilized from modified Dulbecco?s phosphate buffered saline (1X PBS) pH 7.2 ? 7.3 with no calcium, magnesium, or preservatives.
Formulation:
This recombinant protein was 0.2 um filtered and lyophilized from modified Dulbecco?s phosphate buffered saline (1X PBS) pH 7.2 ? 7.3 with no calcium, magnesium, or preservatives.
Long Description:
Immunoglobulin G (IgG) is a monomeric immunoglobulin synthesized and secreted by plasma B cells. It is the most abundant immunoglobulin and is approximately equally distributed in blood and in tissue liquids (1). IgG antibodies are predominately involved in the secondary antibody response (the main antibody involved in primary response is IgM) (2). Pro-inflammatory cytokines particularly IL-4 and IL-2 have a crucial role in activation of the IgG antibody response. IgG is the only isotype that can pass through the human placenta, thereby providing protection to the fetus in utero (3). In addition, residual IgG absorbed through the placenta provides the neonate with humoral immunity before its own immune system develops.
NCBI Gene:
3500
Purity:
>95% by SDS-PAGE and analyzed by silver stain.
Target:
IgG1

References

1. Junqueira, LC. and Carneiro, J. (2003) Basic Histology. Tenth edition, McGraw Hill Companies 2. Meulenbroek, AJ. et al. (1996) Human IgG Subclasses: Useful diagnostic markers for immunocompetence (Sanquin) 3. Pitcher-Wilmott, RW. et al. (1980) Clin. Exp. Immunol. 41:303